The Spectrum of Underlying Causes of Iatrogenic Kaposi's Sarcoma in a Large Series: A Retrospective Study
- PMID: 31543535
- PMCID: PMC6749761
- DOI: 10.4103/ijd.IJD_217_18
The Spectrum of Underlying Causes of Iatrogenic Kaposi's Sarcoma in a Large Series: A Retrospective Study
Abstract
Background: The frequency of clinicoepidemiological variants of Kaposi's sarcoma (KS) differs markedly throughout the world. The iatrogenic variant is mainly associated with the use of immunosuppressive therapy.
Aims: We aimed to investigate the distribution of KS variants in our practice and elucidate the underlying causes of iatrogenic KS.
Methods: Consecutive KS patients seen in a single tertiary center were grouped according to the tumor variants and iatrogenic KS patients were evaluated about associated conditions.
Results: Among 137 patients, classic variant was the most frequent presentation (n = 88), followed by iatrogenic (n = 37) variant. Among the iatrogenic group, ten were transplant recipients. In 16 iatrogenic KS patients, systemic corticosteroid was used, in four for myasthenia gravis (MG) and in three for rheumatoid arthritis. In three patients, KS developed under topical corticosteroid (TC) treatment. Among iatrogenic KS patients, ten of them had a second primary neoplasm and one had congenital immunodeficiency syndrome.
Conclusions: Our study revealed one of the highest rates for iatrogenic KS (27%) reported in the literature. Besides well-known causes, relatively frequent association with MG was remarkable. Usage of different forms of TCs was the cause of KS in a few cases.
Keywords: Corticosteroid; Kaposi's sarcoma; iatrogenic; myasthenia gravis; mycosis fungoides.
Conflict of interest statement
There are no conflicts of interest.
Figures
Similar articles
-
Differential expression of p53 and Ki-67 proteins in classic and iatrogenic Kaposi's sarcoma.Am J Dermatopathol. 1999 Apr;21(2):138-45. doi: 10.1097/00000372-199904000-00005. Am J Dermatopathol. 1999. PMID: 10218673
-
[Kaposi's sarcoma in Tunisia. Review of 91 cases].Tunis Med. 2001 Aug-Sep;79(8-9):429-33. Tunis Med. 2001. PMID: 11774784 French.
-
Iatrogenic Kaposi's sarcoma in myasthenia gravis: learnings from two case reports.Neurol Sci. 2021 May;42(5):2081-2083. doi: 10.1007/s10072-020-04971-9. Epub 2021 Jan 6. Neurol Sci. 2021. PMID: 33404862 Free PMC article.
-
Diagnosis and treatment of classic and iatrogenic Kaposi's sarcoma: Italian recommendations.Ital J Dermatol Venerol. 2021 Jun;156(3):356-365. doi: 10.23736/S2784-8671.20.06703-6. Epub 2020 Nov 12. Ital J Dermatol Venerol. 2021. PMID: 33179877 Review.
-
Rapidly progressive Kaposi's Sarcoma in an Iraqi boy received Valproic acid: a case report and review of literature.BMC Pediatr. 2016 Jul 26;16:111. doi: 10.1186/s12887-016-0653-3. BMC Pediatr. 2016. PMID: 27459853 Free PMC article. Review.
Cited by
-
Outcome markers of ART-treated HIV+ patients with early stage Kaposi's sarcoma.PLoS One. 2020 Jul 7;15(7):e0235865. doi: 10.1371/journal.pone.0235865. eCollection 2020. PLoS One. 2020. PMID: 32634155 Free PMC article.
-
Iatrogenic Kaposi Sarcoma Precipitated by Anti-Tumor Necrosis Factor-Alpha (Anti-TNF-α) Therapy.Cureus. 2021 Feb 16;13(2):e13384. doi: 10.7759/cureus.13384. Cureus. 2021. PMID: 33754107 Free PMC article.
-
Solitary incidental primary Kaposi's sarcoma of the glans penis in a patient with no risk factors.Urol Ann. 2020 Jul-Sep;12(3):283-285. doi: 10.4103/UA.UA_172_19. Epub 2020 Jul 17. Urol Ann. 2020. PMID: 33100756 Free PMC article.
-
Evaluation of secondary malignancies in a large series of mycosis fungoides.An Bras Dermatol. 2024 May-Jun;99(3):370-379. doi: 10.1016/j.abd.2023.06.004. Epub 2024 Jan 22. An Bras Dermatol. 2024. PMID: 38262820 Free PMC article.
-
A description of Kaposi sarcoma risk factors and outcomes in HIV-positive and HIV-negative patients at a tertiary care medical center from 2005 to 2020.Arch Dermatol Res. 2023 Sep;315(7):2159-2162. doi: 10.1007/s00403-023-02552-2. Epub 2023 Mar 1. Arch Dermatol Res. 2023. PMID: 36856854
References
-
- Buonaguro FM, Tornesello ML, Buonaguro L, Satriano RA, Ruocco E, Castello G, et al. Kaposi's sarcoma: Aetiopathogenesis, histology and clinical features. J Eur Acad Dermatol Venereol. 2003;17:138–54. - PubMed
-
- Weissmann A, Linn S, Weltfriend S, Friedman-Birnbaum R. Epidemiological study of classic Kaposi's sarcoma: A retrospective review of 125 cases from Northern Israel. J Eur Acad Dermatol Venereol. 2000;14:91–5. - PubMed
-
- Senturk N, Sahin S, Ercis S, Kocagoz T, Atakan N. Human herpesvirus 8 (HHV-8) in non-HIV associated forms of Kaposi's sarcoma from Turkey. Turk J Med Sci. 2001;31:503–8.
-
- Dogan M, Dogan L, Ozdemir F, Ozdemir NY, Coskun HS, Arslan UY, et al. Fifty-one Kaposi sarcoma patients. Clin Transl Oncol. 2010;12:629–33. - PubMed